Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Doc re. Sale of Investment -

2 Jun 2008 11:45

RNS Number : 7394V
Close Brothers Dev VCT PLC
02 June 2008
 



Close Brothers Development VCT PLC

Sale of investment - movement in net asset value

The Board of Close Brothers Development VCT PLC is pleased to announce the disposal of its investment in Grosvenor Health Limited for a total consideration of £6.25 million, following the sale of the business to Serco Group plc.

Close Brothers Development VCT backed the original management buy-out of the occupational health provider from its former parent, Capio UK, in March 2004, and invested a total of £2.2 million in the Company, both to fund the MBO and finance subsequent acquisitions. The total IRR on Close Brothers Development VCT's investment is around 36%.

As a result of the disposal, the unaudited pro-forma net asset value per share of Close Brothers Development VCT at 31 March 2008 has risen to 105.05 pence per share (this is before accounting for the dividend of 2.50 pence per share which was paid to shareholders on 16 May 2008).

Following the completion of the disposal, Close Brothers Development VCT will re-commence its share buy-back programme forthwith, until the start of its "close" period on 1 July 2007.

2 June 2008

For further information please contact:

Patrick Reeve

020 7422 7830

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DOCFKBKQKBKDDAK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.